Top Markets
Coin of the day
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Kedudukan dalam Saham #40613
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Harga Saham
$0.13607016
Disegerakkan terakhir: 2024-09-10
Modal Pasaran
$112.29K
Perubahan (1 hari)
22.46%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan BiVictriX Therapeutics Plc (BVX)

Kategori

Sejarah hasil dividen untuk BiVictriX Therapeutics Plc (BVX)
Hasil dividen (TTM) bagi BiVictriX Therapeutics Plc (simbol saham: BVX) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk BiVictriX Therapeutics Plc (BVX) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing